يعرض 1 - 10 نتائج من 51 نتيجة بحث عن '"Watkins, Melissa"', وقت الاستعلام: 0.97s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Efficacy and safety of abrocitinib in patients with moderate-to-severe atopic dermatitis with prior exposure to oral systemic immunosuppressants or biologic therapies: a post hoc analysis of the JADE clinical trials

    المؤلفون: Gooderham, Melinda J., Ardern-Jones, Michael R., Guttman-Yassky, Emma, Ameen, Mahreen, Simpson, Eric L., Chan, Gary, Biswas, Pinaki, Chiu, Wing S., Watkins, Melissa

    وصف الملف: text

    العلاقة: https://eprints.soton.ac.uk/490249/1/JEADV_Clinical_Practice_-_2023_-_Gooderham_-_Efficacy_and_safety_of_abrocitinib_in_patients_with_moderate_to_severe_atopic.pdfTest; Gooderham, Melinda J., Ardern-Jones, Michael R., Guttman-Yassky, Emma, Ameen, Mahreen, Simpson, Eric L., Chan, Gary, Biswas, Pinaki, Chiu, Wing S. and Watkins, Melissa (2023) Efficacy and safety of abrocitinib in patients with moderate-to-severe atopic dermatitis with prior exposure to oral systemic immunosuppressants or biologic therapies: a post hoc analysis of the JADE clinical trials. JEADV Clinical Practice, 2 (4), 753-763. (doi:10.1002/jvc2.203 ).

    الإتاحة: https://doi.org/10.1002/jvc2.203Test
    https://eprints.soton.ac.uk/490249Test/
    https://eprints.soton.ac.uk/490249/1/JEADV_Clinical_Practice_-_2023_-_Gooderham_-_Efficacy_and_safety_of_abrocitinib_in_patients_with_moderate_to_severe_atopic.pdfTest

    View record in BASE

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Abrocitinib Provides Rapid and Sustained Improvement in Skin Pain and Is Associated with Improved Quality of Life Outcomes in Adult and Adolescent Patients with Moderate-to-Severe Atopic Dermatitis

    المؤلفون: Thyssen, Jacob P., Bewley, Anthony, Ständer, Sonja, Castro, Carla, Misery, Laurent, Kim, Brian S., Biswas, Pinaki, Chan, Gary, Myers, Daniela E., Watkins, Melissa, Alderfer, Justine, Güler, Erman, Silverberg, Jonathan I.

    المصدر: Dermatology ; volume 240, issue 2, page 243-253 ; ISSN 1018-8665 1421-9832

    الإتاحة: https://doi.org/10.1159/000535285Test
    https://karger.com/drm/article-pdf/240/2/243/4189442/000535285.pdfTest

    View record in BASE

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    542 - Validation of the skin pain numerical rating scale of the Pruritus and Symptoms Assessment for Atopic Dermatitis for adults and adolescents with moderate-to-severe atopic dermatitis

    المؤلفون: Silverberg, Jonathan I, Ständer, Sonja, Kim, Brian S, Bewley, Anthony, Misery, Laurent, Vestergaard, Christian, Gooderham, Melinda J, Bushmakin, Andrew G, Cappelleri, Joseph C, Güler, Erman, Alderfer, Justine, Watkins, Melissa, Selfridge, Andrew, Myers, Daniela E

    المصدر: British Journal of Dermatology ; volume 190, issue Supplement_2, page ii41-ii42 ; ISSN 0007-0963 1365-2133

    مصطلحات موضوعية: Dermatology

    الإتاحة: https://doi.org/10.1093/bjd/ljad498.043Test
    https://academic.oup.com/bjd/article-pdf/190/Supplement_2/ii41/56590518/ljad498.043.pdfTest

    View record in BASE

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Abrocitinib Provides Rapid and Sustained Improvement in Skin Pain and Is Associated with Improved Quality of Life Outcomes in Adult and Adolescent Patients with Moderate-to-Severe Atopic Dermatitis.

    المؤلفون: Thyssen, Jacob P., Bewley, Anthony, Ständer, Sonja, Castro, Carla, Misery, Laurent, Kim, Brian S., Biswas, Pinaki, Chan, Gary, Myers, Daniela E., Watkins, Melissa, Alderfer, Justine, Güler, Erman, Silverberg, Jonathan I.

    المصدر: Dermatology (10188665); 2024, Vol. 240 Issue 2, p243-253, 11p

    مصطلحات موضوعية: ATOPIC dermatitis, QUALITY of life, ADULTS, TEENAGERS, ITCHING, PAIN threshold, ECZEMA


    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    Efficacy and safety of abrocitinib in patients with moderate‐to‐severe atopic dermatitis with prior exposure to oral systemic immunosuppressants or biologic therapies: A post hoc analysis of the JADE clinical trials.

    المؤلفون: Gooderham, Melinda J., Ardern‐Jones, Michael R., Guttman‐Yassky, Emma, Ameen, Mahreen, Simpson, Eric L., Chan, Gary, Biswas, Pinaki, Chiu, Wing S., Watkins, Melissa

    المصدر: JEADV Clinical Practice; Dec2023, Vol. 2 Issue 4, p753-763, 11p

    النص الكامل

    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    Abrocitinib 100 mg Once Daily for Moderate-to-Severe Atopic Dermatitis: A Review of Efficacy and Safety, and Expert Opinion on Use in Clinical Practice.

    المؤلفون: Gooderham, Melinda J., Pink, Andrew E., Simpson, Eric L., Silverberg, Jonathan I., Güler, Erman, Watkins, Melissa

    المصدر: Dermatology & Therapy; Sep2023, Vol. 13 Issue 9, p1893-1907, 15p

    النص الكامل

    أضف إلى المفضلة
  7. 7
    Effect of abrocitinib vs. dupilumab on skin pain: an analysis of the phase 3 JADE COMPARE and JADE DARE trials

    المؤلفون: Thyssen, Jacob P., Bewley, Anthony, Ständer, Sonja, Castro, Carla, Misery, Laurent, von Kobyletzki, Laura B., 1971, Silverberg, Jonathan, I, Kim, Brian S., Biswas, Pinaki, Chan, Gary, Myers, Daniela E., Watkins, Melissa, Alderfer, Justine, Güler, Erman

    المصدر: British Journal of Dermatology. 188(Suppl. 3)

    مصطلحات موضوعية: abrocitinib, dupilumab, moderate-to-severe, atopic dermatitis, skin pain

    وصف الملف: print

    الوصول الحر: https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-107927Test


    أضف إلى المفضلة
  8. 8
    دورية أكاديمية
    Abrocitinib 100 mg Once Daily for Moderate-to-Severe Atopic Dermatitis: A Review of Efficacy and Safety, and Expert Opinion on Use in Clinical Practice

    المؤلفون: Gooderham, Melinda J, Pink, Andrew E, Simpson, Eric L, Silverberg, Jonathan I, Güler, Erman, Watkins, Melissa

    المصدر: GW Authored Works

    مصطلحات موضوعية: Abrocitinib, Clinical practice, Flexible dosing, JAK1-selective inhibitor, Moderate-to-severe atopic dermatitis, Oral systemic therapy, Shared decision-making

    العلاقة: https://hsrc.himmelfarb.gwu.edu/gwhpubs/3039Test; https://doi.org/10.1007/s13555-023-00948-6Test

    الإتاحة: https://doi.org/10.1007/s13555-023-00948-6Test
    https://hsrc.himmelfarb.gwu.edu/gwhpubs/3039Test

    View record in BASE

    أضف إلى المفضلة
  9. 9
    دورية أكاديمية
    423 Long-term efficacy of abrocitinib up to 96 weeks in adults with moderate-to-severe atopic dermatitis stratified by age: a post hoc analysis of the JADE EXTEND phase 3 trial

    المؤلفون: Alexis, Andrew F, Deleuran, Mette, Silverberg, Jonathan I, Gooderham, Melinda J, Farooqui, Saleem A, Chan, Gary, Koppensteiner, Herwig, Biswas, Pinaki, Watkins, Melissa

    المصدر: British Journal of Dermatology ; volume 188, issue Supplement_3 ; ISSN 0007-0963 1365-2133

    مصطلحات موضوعية: Dermatology

    الإتاحة: https://doi.org/10.1093/bjd/ljad162.043Test
    https://academic.oup.com/bjd/article-pdf/188/Supplement_3/ljad162.043/50647858/ljad162.043.pdfTest

    View record in BASE

    أضف إلى المفضلة
  10. 10
    دورية أكاديمية
    351 Examining the relationships among abrocitinib treatment, itch, skin pain and dermatology-specific quality of life in patients with atopic dermatitis: a mediation modelling analysis

    المؤلفون: Silverberg, Jonathan I, Ständer, Sonja, Thyssen, Jacob P, Kim, Brian S, Castro, Carla, Bewley, Anthony, Misery, Laurent, Bushmakin, Andrew G, Cappelleri, Joseph C, Guler, Erman, Alderfer, Justine, Watkins, Melissa, Chan, Gary, Myers, Daniela E

    المصدر: British Journal of Dermatology ; volume 188, issue Supplement_2 ; ISSN 0007-0963 1365-2133

    مصطلحات موضوعية: Dermatology

    الإتاحة: https://doi.org/10.1093/bjd/ljac140.043Test
    https://academic.oup.com/bjd/article-pdf/188/Supplement_2/ljac140.043/48846078/ljac140.043.pdfTest

    View record in BASE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث